Buspirone Hydrochloride
Product Images NDC 75834-267

16 FDA label images from Nivagen Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 75834-267). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buspirone 01)

Chemical Structure (Buspirone 01)
Chemical structure of Buspirone Hydrochloride showing the molecular arrangement including a piperazine ring, cyclohexane rings, and associated functional groups depicted in a line-angle formula format.*
FDA Label Image

Image (Buspirone 02)

Image (Buspirone 02)
Image shows two white, oblong tablets imprinted with "100" and "555" on one side, respectively. These tablets correspond to Buspirone Hydrochloride as labeled by Nivagen Pharmaceuticals Inc.*
FDA Label Image

Image (Buspirone 03)

Image (Buspirone 03)
Packaging label of Buspirone Hydrochloride tablet imprinted with '5' on both sides, indicating a 5 mg strength. The tablet is round and white. Labeler name Nivagen Pharmaceuticals Inc. is associated with this product.*
FDA Label Image

Image (Buspirone 04)

FDA Label Image

Image (Buspirone 05)

Image (Buspirone 05)
The image shows a white, rounded square tablet with the imprint "5" on one side. This tablet is likely Buspirone Hydrochloride, a medication provided by Nivagen Pharmaceuticals Inc., with a strength of 5 mg as indicated by the imprint.*
FDA Label Image

Image (Buspirone 06)

Image (Buspirone 06)
An instructional line drawing showing hands holding a tablet and breaking it in half by applying pressure with the thumbs. This illustration demonstrates how to split the tablet, likely for dosing purposes.*
FDA Label Image

Image (Buspirone 07)

Image (Buspirone 07)
Image of two white, oblong tablets imprinted with numbers. One tablet shows '1 01' on one side, the other tablet shows '10 10 10' on its side. These tablets are identified as Buspirone Hydrochloride by Nivagen Pharmaceuticals Inc.*
FDA Label Image

Image (Buspirone 08)

Image (Buspirone 08)
Buspirone Hydrochloride 10 mg tablet imprints showing '10' on one side and '10' on the other side, indicating the dosage strength. The round, white tablet is divided by a score line. Labeler is Nivagen Pharmaceuticals Inc.*
FDA Label Image

Image (Buspirone 09)

Image (Buspirone 09)
Buspirone Hydrochloride tablet imprinted with the number '10' on one side and '1' on the other, shown in white, round, scored tablet form. The image does not show additional packaging or labeling details.*
FDA Label Image

Image (Buspirone 10)

Image (Buspirone 10)
The image shows a white, round tablet with one side scored and the number '10' printed on it. This tablet is identified as Buspirone Hydrochloride 10 mg, manufactured by Nivagen Pharmaceuticals Inc.*
FDA Label Image

Image (Buspirone 11)

Image (Buspirone 11)
An instructional line drawing showing hands holding and twisting a tablet to split it evenly, demonstrating how to break tablets into halves.*
FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Principal Display Panel (5 mg Tablet Bottle Label)
Buspirone Hydrochloride Tablets, USP 5 mg in a bottle label showing 100 tablets. The label includes storage instructions, dosage notes, manufacturer information for Nivagen Pharmaceuticals Inc., a barcode, QR code, and lot and expiration date placeholders. The label indicates prescription use only.*
FDA Label Image

Principal Display Panel (7.5 mg Tablet Bottle Label)

Principal Display Panel (7.5 mg Tablet Bottle Label)
Label for Buspirone Hydrochloride Tablets, USP 7.5 mg, containing 100 tablets. The label includes the NDC number 75834-267-01 and notes that the product is manufactured for Nivagen Pharmaceuticals Inc. It provides storage instructions, dosage advisory to see the package insert, child-resistant container information, and manufacturing details for Inventia Healthcare Limited in India. The label also features a barcode and a QR code with lot, manufacturing, and expiration date placeholders.*
FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Principal Display Panel (10 mg Tablet Bottle Label)
Buspirone Hydrochloride 10 mg Tablets, USP packaging label showing 100 tablets from Nivagen Pharmaceuticals Inc. The label includes dosage strength, quantity, and storage instructions. It also displays manufacturer information, a barcode, and warnings to keep out of reach of children.*
FDA Label Image

Principal Display Panel (15 mg Tablet Bottle Label)

Principal Display Panel (15 mg Tablet Bottle Label)
Buspirone Hydrochloride Tablets, USP 15 mg label for a 100-tablet bottle by Nivagen Pharmaceuticals Inc. The label includes storage instructions (20° to 25°C), dispensing information, manufacturer details in India, barcode, and a note for pharmacists to dispense with the patient information leaflet.*
FDA Label Image

Principal Display Panel (30 mg Tablet Bottle Label)

Principal Display Panel (30 mg Tablet Bottle Label)
Buspirone Hydrochloride Tablets, USP 30 mg, 60 count bottle label by Nivagen Pharmaceuticals Inc. The label shows dosage strength, quantity, NDC 75834-270-60, storage instructions, manufacturer details including Inventia Healthcare Limited in India, and includes warnings and pharmacist dispensing instructions. The label displays barcodes and lot, manufacturing, and expiration date placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.